Cytotoxic impact of a perillyl alcohol-temozolomide conjugate, NEO212, on cutaneous T-cell lymphoma in vitro.
Catalina Silva-HirschbergHannah HartmanSamantha StackSteve SwensonRadu O MineaMichael A DavitzThomas C ChenAxel H SchönthalPublished in: Therapeutic advances in medical oncology (2019)
NEO212 exerted promising anticancer effects on SS and MF cell lines. The generation of reactive oxygen species (ROS) appears to play a key role in the NEO212-induced cell death process, because the blockage of ROS with antioxidants prevented caspase activation. We propose that NEO212 should be investigated further toward clinical testing in these tumor types.